Vanguard Portfolio Management’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CAM
CCM
GCM
Vanguard Portfolio Management's LMAT Position: Q2 2026 in Review
Vanguard Portfolio Management increased its LeMaitre Vascular (LMAT) stake by 7.5% in Q2 2026, buying an estimated $4.31M and bringing the position to 604,833 shares worth $58M. The position accounts for ﹤0.01% of the portfolio, ranked #1677.
Vanguard Portfolio Management first reported a position in LMAT in Q1 2026 and has held it in 2 quarters since. The position peaked at $61.4M in Q1 2026. 325 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- Vanguard Portfolio Management held 604,833 shares of LeMaitre Vascular worth $58M as of Q2 2026.
- Vanguard Portfolio Management bought 42,063 LeMaitre Vascular shares in Q2 2026, an estimated $4.31M.
- LeMaitre Vascular made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #1677 holding.
- Vanguard Portfolio Management first reported a position in LeMaitre Vascular in Q1 2026 and has held it in 2 quarters since.
- Vanguard Portfolio Management's LeMaitre Vascular position peaked at $61.4M in Q1 2026.
- 325 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.